BioTech Company Named In Investor Suit Over COVID-Related Nondisclosures
BROOKLYN, N.Y. — A biotechnology company and certain of its senior executives violated federal securities laws by misrepresenting the impact the novel coronavirus pandemic was having on the company’s submission schedule...To view the full article, register now.
Already a subscriber? Click here to view full article